CB Oncology Partners (Tables)

6 Months Ended

Jun. 30, 2023

CB Oncology Partners LLC [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following table presents the summarized financial information of CBOP:

CBOP Condensed Income Statement Information

	Six Months Ended
	June 30,
	2023				2022
Patient revenue		$	761,000			$	1,026,000
Net (loss) income		$	(607,000	)		$	(237,000	)
USNC’s equity in (loss) income of CBOP		$	(173,000	)		$	(68,000	)

	Three Months Ended
	June 30,
	2023				2022
Patient revenue		$	443,000			$	44,000
Net (loss) income		$	(320,000	)		$	(191,000	)
USNC’s equity in (loss) income of CBOP		$	(91,000	)		$	(55,000	)

CBOP Condensed Balance Sheet Information

	June 30,			December 31,
	2023			2022
Current assets	$	347,000		$	405,000
Noncurrent assets		2,763,000			3,056,000
Total assets	$	3,110,000		$	3,461,000
Current liabilities	$	3,909,000		$	975,000
Noncurrent liabilities		2,868,000			5,680,000
Deficit		(3,667,000	)		(3,194,000	)
Total liabilities and deficit	$	3,110,000		$	3,461,000